Klopidogrel (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Klopidogrel" in Turkish language version.

refsWebsite

Global rank Turkish rank

15nih.gov

4^th place

11^th place

14doi.org

2^nd place

4^th place

11web.archive.org

1^st place

2drugs.com

399^th place

156^th place

2clincalc.com

3,912^th place

2,106^th place

1books.google.com

3^rd place

5^th place

1worldcat.org

5^th place

8^th place

1jamanetwork.com

2,650^th place

9,802^nd place

1europa.eu

68^th place

79^th place

1theheart.org

low place

1archive.org

6^th place

1webmd.com

1,169^th place

378^th place

1fda.gov

447^th place

858^th place

archive.org

"Clopidogrel-Associated TTP An Update of Pharmacovigilance Efforts Conducted by Independent Researchers, Pharmaceutical Suppliers, and the Food and Drug Administration". Stroke. 35 (2): 533-8. 2004. doi:10.1161/01.STR.0000109253.66918.5E. PMID 14707231. KB1 bakım: göster-yazarlar (link)

books.google.com

Analogue-based Drug Discovery. John Wiley & Sons. 2006. s. 453. ISBN 9783527607495. 20 Aralık 2016 tarihinde kaynağından arşivlendi.

clincalc.com

"The Top 300 of 2020". ClinCalc. 16 Mart 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
"Clopidogrel - Drug Usage Statistics". ClinCalc. 10 Haziran 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.

doi.org

"2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". J. Am. Coll. Cardiol. 61 (4): e78-140. January 2013. doi:10.1016/j.jacc.2012.11.019. PMID 23256914. KB1 bakım: göster-yazarlar (link)
"2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines". Circulation. 126 (7): 875-910. August 2012. doi:10.1161/CIR.0b013e318256f1e0. PMID 22800849. KB1 bakım: göster-yazarlar (link)
"2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 126 (25): 3097-137. December 2012. doi:10.1161/CIR.0b013e3182776f83. PMID 23166210. KB1 bakım: göster-yazarlar (link)
"Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison". BMJ (Clinical Research Ed.). 347: f5307. 17 Eylül 2013. doi:10.1136/bmj.f5307. PMC 3775704 $2. PMID 24046285. KB1 bakım: göster-yazarlar (link)
"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding". N. Engl. J. Med. 352 (3): 238-44. 2005. doi:10.1056/NEJMoa042087. PMID 15659723. KB1 bakım: göster-yazarlar (link)
"Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence". Indian Journal of Pharmacology. 43 (2): 183-6. 2011. doi:10.4103/0253-7613.77360. PMC 3081459 $2. PMID 21572655. KB1 bakım: göster-yazarlar (link)
"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome". Journal of the American Medical Association. 301 (9): 937-44. 2009. doi:10.1001/jama.2009.261. PMID 19258584. KB1 bakım: göster-yazarlar (link)
"Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor". Arch Intern Med. 170 (8): 704-10. April 2010. doi:10.1001/archinternmed.2010.34. ISSN 1538-3679. PMID 20421557. 4 Mart 2016 tarihinde kaynağından (PDF) arşivlendi. KB1 bakım: göster-yazarlar (link)
"Clopidogrel-Associated TTP An Update of Pharmacovigilance Efforts Conducted by Independent Researchers, Pharmaceutical Suppliers, and the Food and Drug Administration". Stroke. 35 (2): 533-8. 2004. doi:10.1161/01.STR.0000109253.66918.5E. PMID 14707231. KB1 bakım: göster-yazarlar (link)
"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial". The Lancet. 364 (9431): 331-7. 2004. doi:10.1016/S0140-6736(04)16721-4. PMID 15276392. KB1 bakım: göster-yazarlar (link)
"Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016". Eur. J. Clin. Pharmacol. 75 (2): 227-235. February 2019. doi:10.1007/s00228-018-2564-8. PMID 30324301. KB1 bakım: göster-yazarlar (link)
"Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update". Drug Safety. 37 (4): 201-11. 2014. doi:10.1007/s40264-014-0144-0. PMC 3975086 $2. PMID 24550106.
"Current Oral Antiplatelets: Focus Update on Prasugrel". The Journal of the American Board of Family Medicine. 25 (3): 343-349. 2012. doi:10.3122/jabfm.2012.03.100270. PMID 22570398.
"Antiplatelet effects and pharmacodynamics of clopidogrel in cats". J Am Vet Med Assoc. 225 (9): 1406-1411. 2004. doi:10.2460/javma.2004.225.1406. PMID 15552317. KB1 bakım: göster-yazarlar (link)

drugs.com

"Clopidogrel Bisulfate". The American Society of Health-System Pharmacists. 21 Aralık 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Aralık 2016.
"Clopidogrel (Plavix) Use During Pregnancy". Drugs.com. 21 Aralık 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Aralık 2016.

europa.eu

ema.europa.eu

"Public statement on possible interaction between clopidogrel and proton pump inhibitors" (PDF). 6 Şubat 2011 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 31 Mart 2011. Yazar |ad1= eksik |soyadı1= (yardım)

fda.gov

"Public Health Advisory: Updated Safety Information about a drug interaction between Clopidogrel Bisulfate (marketed as Plavix) and Omeprazole (marketed as Prilosec and Prilosec OTC)". Food and Drug Administration (FDA). 17 Kasım 2009. 29 Aralık 2009 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2010.

jamanetwork.com

archinte.jamanetwork.com

"Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor". Arch Intern Med. 170 (8): 704-10. April 2010. doi:10.1001/archinternmed.2010.34. ISSN 1538-3679. PMID 20421557. 4 Mart 2016 tarihinde kaynağından (PDF) arşivlendi. KB1 bakım: göster-yazarlar (link)

nih.gov

ncbi.nlm.nih.gov

"2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". J. Am. Coll. Cardiol. 61 (4): e78-140. January 2013. doi:10.1016/j.jacc.2012.11.019. PMID 23256914. KB1 bakım: göster-yazarlar (link)
"2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines". Circulation. 126 (7): 875-910. August 2012. doi:10.1161/CIR.0b013e318256f1e0. PMID 22800849. KB1 bakım: göster-yazarlar (link)
"2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 126 (25): 3097-137. December 2012. doi:10.1161/CIR.0b013e3182776f83. PMID 23166210. KB1 bakım: göster-yazarlar (link)
"Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison". BMJ (Clinical Research Ed.). 347: f5307. 17 Eylül 2013. doi:10.1136/bmj.f5307. PMC 3775704 $2. PMID 24046285. KB1 bakım: göster-yazarlar (link)
"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding". N. Engl. J. Med. 352 (3): 238-44. 2005. doi:10.1056/NEJMoa042087. PMID 15659723. KB1 bakım: göster-yazarlar (link)
"Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence". Indian Journal of Pharmacology. 43 (2): 183-6. 2011. doi:10.4103/0253-7613.77360. PMC 3081459 $2. PMID 21572655. KB1 bakım: göster-yazarlar (link)
"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome". Journal of the American Medical Association. 301 (9): 937-44. 2009. doi:10.1001/jama.2009.261. PMID 19258584. KB1 bakım: göster-yazarlar (link)
"Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor". Arch Intern Med. 170 (8): 704-10. April 2010. doi:10.1001/archinternmed.2010.34. ISSN 1538-3679. PMID 20421557. 4 Mart 2016 tarihinde kaynağından (PDF) arşivlendi. KB1 bakım: göster-yazarlar (link)
"Clopidogrel-Associated TTP An Update of Pharmacovigilance Efforts Conducted by Independent Researchers, Pharmaceutical Suppliers, and the Food and Drug Administration". Stroke. 35 (2): 533-8. 2004. doi:10.1161/01.STR.0000109253.66918.5E. PMID 14707231. KB1 bakım: göster-yazarlar (link)
"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial". The Lancet. 364 (9431): 331-7. 2004. doi:10.1016/S0140-6736(04)16721-4. PMID 15276392. KB1 bakım: göster-yazarlar (link)
"Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016". Eur. J. Clin. Pharmacol. 75 (2): 227-235. February 2019. doi:10.1007/s00228-018-2564-8. PMID 30324301. KB1 bakım: göster-yazarlar (link)
"Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update". Drug Safety. 37 (4): 201-11. 2014. doi:10.1007/s40264-014-0144-0. PMC 3975086 $2. PMID 24550106.
"Current Oral Antiplatelets: Focus Update on Prasugrel". The Journal of the American Board of Family Medicine. 25 (3): 343-349. 2012. doi:10.3122/jabfm.2012.03.100270. PMID 22570398.
"Antiplatelet effects and pharmacodynamics of clopidogrel in cats". J Am Vet Med Assoc. 225 (9): 1406-1411. 2004. doi:10.2460/javma.2004.225.1406. PMID 15552317. KB1 bakım: göster-yazarlar (link)

dailymed.nlm.nih.gov

"Plavix- clopidogrel bisulfate tablet, film coated". DailyMed. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. 17 Mayıs 2019. 4 Ağustos 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Aralık 2019.

theheart.org

"EMEA issues warning on possible clopidogrel-PPI interaction, but is there really a problem?". 22 Mayıs 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 31 Mart 2011. Yazar |ad1= eksik |soyadı1= (yardım)

web.archive.org

"Clopidogrel Bisulfate". The American Society of Health-System Pharmacists. 21 Aralık 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Aralık 2016.
"Clopidogrel (Plavix) Use During Pregnancy". Drugs.com. 21 Aralık 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Aralık 2016.
"Plavix- clopidogrel bisulfate tablet, film coated". DailyMed. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. 17 Mayıs 2019. 4 Ağustos 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Aralık 2019.
Analogue-based Drug Discovery. John Wiley & Sons. 2006. s. 453. ISBN 9783527607495. 20 Aralık 2016 tarihinde kaynağından arşivlendi.
"The Top 300 of 2020". ClinCalc. 16 Mart 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
"Clopidogrel - Drug Usage Statistics". ClinCalc. 10 Haziran 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
"Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor". Arch Intern Med. 170 (8): 704-10. April 2010. doi:10.1001/archinternmed.2010.34. ISSN 1538-3679. PMID 20421557. 4 Mart 2016 tarihinde kaynağından (PDF) arşivlendi. KB1 bakım: göster-yazarlar (link)
"Public statement on possible interaction between clopidogrel and proton pump inhibitors" (PDF). 6 Şubat 2011 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 31 Mart 2011. Yazar |ad1= eksik |soyadı1= (yardım)
"EMEA issues warning on possible clopidogrel-PPI interaction, but is there really a problem?". 22 Mayıs 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 31 Mart 2011. Yazar |ad1= eksik |soyadı1= (yardım)
"FDA Warns Plavix Patients of Drug Interactions". WebMD. 23 Şubat 2016. 23 Şubat 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 23 Kasım 2009. Yazar |ad1= eksik |soyadı1= (yardım)
"Public Health Advisory: Updated Safety Information about a drug interaction between Clopidogrel Bisulfate (marketed as Plavix) and Omeprazole (marketed as Prilosec and Prilosec OTC)". Food and Drug Administration (FDA). 17 Kasım 2009. 29 Aralık 2009 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Mart 2010.

webmd.com

"FDA Warns Plavix Patients of Drug Interactions". WebMD. 23 Şubat 2016. 23 Şubat 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 23 Kasım 2009. Yazar |ad1= eksik |soyadı1= (yardım)

worldcat.org

"Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor". Arch Intern Med. 170 (8): 704-10. April 2010. doi:10.1001/archinternmed.2010.34. ISSN 1538-3679. PMID 20421557. 4 Mart 2016 tarihinde kaynağından (PDF) arşivlendi. KB1 bakım: göster-yazarlar (link)